Cargando…

Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective

Without stringent criteria, liver transplantation for hepatocellular carcinoma (HCC) can lead to high cancer recurrence and poor prognosis in the current treatment context. Checkpoint inhibitors can lead to long survival by targeting coinhibitory pathways and promoting T-cell activity; thus, they ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Cheng-Maw, Chen, Hui-Ling, Hu, Rey-Heng, Lee, Po-Huang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487770/ https://www.ncbi.nlm.nih.gov/pubmed/31065295 http://dx.doi.org/10.1177/1758835919843463

Ejemplares similares

Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma
por: Yang, Po-Chih, et al.
Publicado: (2016)

Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation
por: Ho, Cheng-Maw, et al.
Publicado: (2020)

Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis
por: Ho, Cheng-Maw, et al.
Publicado: (2021)

Do Liver Transplant Recipients Have a Higher Risk for Cryptococcosis Than Non-liver Transplant Recipients?
por: Sun, Hsin-Yun, et al.
Publicado: (2017)

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series
por: Wong, Ta-Hsiang, et al.
Publicado: (2022)

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Editorial: Transplant Oncology of Liver Malignancies
por: Ho, Cheng-Maw
Publicado: (2022)

Hepatocellular Carcinoma: The Role of Immunotherapy and Transplantation in the Era of Transplant Oncology
por: Alghamdi, Saad, et al.
Publicado: (2023)

Circuitous Path to Live Donor Liver Transplantation from the Coordinator’s Perspective
por: Lin, Hui-Ying, et al.
Publicado: (2021)

Hepatocyte and mesenchymal stem cell co-transplantation in rats with acute liver failure
por: Ho, Cheng-Maw, et al.
Publicado: (2020)

Post-Transplant Malignancy in Liver Transplantation: A Single Center Experience
por: Hsiao, Chih-Yang, et al.
Publicado: (2014)

Succinct guide to liver transplantation for medical students
por: Ho, Cheng-Maw, et al.
Publicado: (2016)

Utilization of Immunotherapy for the Treatment of Hepatocellular Carcinoma in the Peri-Transplant Setting: Transplant Oncology View
por: Abdelrahim, Maen, et al.
Publicado: (2022)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
por: Hussaarts, Koen G. A. M., et al.
Publicado: (2021)

Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons
por: Luo, Yi, et al.
Publicado: (2022)

Dynamic Prognostication in Transplant Candidates with Acute-on-Chronic Liver Failure
por: Lu, Cheng-Yueh, et al.
Publicado: (2020)

Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation
por: Ouranos, Konstantinos, et al.
Publicado: (2022)

Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma
por: Woo, Stephanie M., et al.
Publicado: (2022)

Immunotherapy for Hepatocellular Carcinoma in the Setting of Liver Transplantation: A Review
por: Lominadze, Zurabi, et al.
Publicado: (2023)

Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
por: Zucker, Kelly M., et al.
Publicado: (2021)

Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation
por: Hsiao, Chih-Yang, et al.
Publicado: (2021)

Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014)

Risk assessment criteria in liver transplantation for hepatocellular carcinoma: proposal to improve transplant oncology
por: McVey, John C, et al.
Publicado: (2020)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
por: Shetty, Kirti, et al.
Publicado: (2014)

Efficient undergraduate learning of liver transplant: building a framework for teaching subspecialties to medical students
por: Ho, Cheng-Maw, et al.
Publicado: (2018)

Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
por: Yu, Jiwoong, et al.
Publicado: (2018)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution
por: Cesario, Silvia, et al.
Publicado: (2023)

Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
por: He, Yuqing, et al.
Publicado: (2021)

Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study
por: Wang, Pusen, et al.
Publicado: (2016)

Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
por: Kim, Dong-Hyun
Publicado: (2022)

Preclinical Application of Reduced Manipulated Processing Strategy to Collect Transplantable Hepatocytes: A Pilot and Feasibility Study
por: Chen, Ya-Hui, et al.
Publicado: (2021)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered?
por: Giacomoni, Alessandro, et al.
Publicado: (2019)

Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma
por: Atanasov, Georgi, et al.
Publicado: (2020)

Expression Patterns of Tumor Markers in Liver Transplant Recipients Showing Complete Pathological Response of Hepatocellular Carcinoma
por: Kim, Min-Jae, et al.
Publicado: (2022)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Is the Rationale of Anatomical Liver Resection for Hepatocellular Carcinoma Universally Adoptable? A Hypothesis-Driven Review
por: Lin, Young-Jen, et al.
Publicado: (2021)

1383. Everolimus is Associated with an Increased Risk of Tuberculosis in Solid-Organ Transplant Recipients
por: Sun, Hsin-Yun, et al.
Publicado: (2019)

Liver Transplantation With Incidental Gallbladder Carcinoma in the Recipient Hepatectomy
por: Kennethwashburn, W., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_l64tnh0gmg40g93n3njr8uorgr